Vocal nodules represent 16 % of benign vocal fold lesions.They are caused by chronic voice abuse or misuse and often occur in children and adult females. The resultant dysphonia leads to personal, social and occupational problems. The first line of treatment is voice rest and voice therapy. The Accent method is a holistic technique for behavior readjustment voice therapy which targets various voice parameters as loudness, pitch and timbre. However, voice rest and voice therapy are sometimes difficult to be carried out in patients with voice-related occupations. So, complete resolution may not be possible in all patients. When voice therapy is inefficient, resection is performed by laryngeal microsurgery under general anesthesia. However, the role of surgery is much restricted.
An intralesional steroid injection to vocal nodules has come to the forefront as another treatment choice. Steroids decrease the synthesis and maturation of collagen, suppress fibroblast function, and inhibit the antibacterial phagocytic action of some defense cells and vasoactive substances release.These actions are considered to be functional for treating vocal nodules. Many studies, investigated steroid injection in benign lesions including nodules, reported that 93-100% of the nodules either disappeared or improved. The reported nodules recurrence rate after 2 years was 26.7- 31%. However, to our knowledge, no previous study has compared vocal nodule steroid injection with a group receiving voice therapy to accurately assess the clinical role of vocal fold steroid injection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
50
0.1- 0.3 mm percutaneous intralesional injection
regular sessions of smith accent voice therapy (about 24 sessions, twice session / week) for 3 months
Assiut university hospitals
Asyut, Egypt
Subjective measurements of severity of dysphonia
Measurements of change of Grade of Dysphonia, Roughness, Breathiness, Asthenia, and Straining by auditory perceptual assessment using the GRBAS scale. Grades ranging from 0 (normal) up to 3 (severe)
Time frame: Before intervention
Subjective measurements of patient's assessment of voice severity
Measurements of scores of Arabic Voice Handicap Index
Time frame: Before intervention
Objective measurements of vocal nodules size
Measurements of base and rise of nodules using videostroboscopic examination
Time frame: before intervention
Objective measurements of vocal pitch
Measurements of acoustic analysis: fundamental frequency (Hz)
Time frame: Before intervention
Objective measurements of vocal waveform frequency aperiodicity
Measurements of acoustic analysis: jitter (%)
Time frame: Before intervention
Objective measurements of vocal waveform amplitude aperiodicity
Measurements of acoustic analysis: shimmer (dB)
Time frame: Before intervention
Objective measurements of vocal waveform periodicity to aperiodicity ratio
Measurements of acoustic analysis : harmonic to noise ratio(dB)
Time frame: Before intervention
Objective measurements of glottal efficiency
Measurements of aerodynamic parameter : Maximum phonation time (seconds)
Time frame: Before intervention
Change in Subjective measurements of severity dysphonia
Measurements of change of Grade of Dysphonia, Roughness, Breathiness, Asthenia, and Straining by auditory perceptual assessment using the GRBAS scale. Grades ranging from 0 (normal) up to 3 (severe)
Time frame: 1 week and 1, 2, 3, and 6 months after intervention
Change in subjective measurements of patient's assessment of voice severity
Measurements of change in scores of Arabic Voice Handicap Index
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of vocal nodules size
Measurements of change in base and rise of nodules using videostroboscopic examination
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of vocal pitch
Measurements of change in acoustic analysis including fundamental frequency (Hz)
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of vocal waveform frequency aperiodicity
Measurements of change in acoustic analysis : jitter (%)
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of vocal waveform amplitude aperiodicity
Measurements of change in acoustic analysis : shimmer (dB)
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of vocal waveform periodicity to aperiodicity ratio
Change in measurements of acoustic analysis : harmonic to noise ratio (dB)
Time frame: 1 week and 1, 2, 3 and 6 months after intervention
Change in objective measurements of glottal efficiency
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Measurements of change in aerodynamic parameter: Maximum phonation time (seconds)
Time frame: 1 week and 1, 2, 3 and 6 months after intervention